Specialist Liverpool manufacturer, ChargePoint Technology has reported annual sales of £8.3m for 2015, a rise of 9%.
Based in Speke, the firm provides precision containment valves to some of the world’s largest pharmaceutical and chemicals companies; and was last week named as one of Merseyside’s fastest growing companies.
Growth has been reportedly driven by the global roll out of a patented new valve system, which has taken the company in to the bio-pharma market, along with sales of existing products in to the US, European and Asian markets.
ChargePoint’s customers use containment valves to enable the safe transfer and handling of any powders used in the manufacturing process – for example when making drugs in tablet form.
The company’s biggest marketplace is the US, where it achieved 20% of revenues from customers which include Merck, Roche Genentech and Johnson & Johnson.
In the UK, GSK and Aptuit are served by the business; while in European sales have been led by Switzerland, Germany and Belgium from pharma heavyweights such as Roche; Pfizer; Novartis; Teva, and Sanofi.
During 2015, China led ChargePoint’s progress in Asia.
Managing director, Chris Eccles commented: “Pharma companies [in China] are looking to export into the West.
“They have to adapt and meet our standards and regulatory requirements, and so are turning to proven Western tech such as ours.”